Treace Medical Concepts, Inc. (TMCI) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 155.01M |
| Enterprise Value | 158.28M |
| P/E Ratio | -4.6 |
| PEG Ratio | 0.26 |
| Price/Sales Ratio | 1.36 |
| Price/Book Ratio | 4.11 |
| Enterprise/Revenue | 1.65 |
| Enterprise/EBITDA | -7.48 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.29 |
| Operating Margin | -0.26 |
AD
Management Effectiveness
| Return On Assets | -0.33 |
| Return On Equity | -0.74 |
Income Statement
| Revenue | 212.69M |
| Revenue/Share | 3.16 |
| Gross Profit | 169.75M |
| EBITDA | -43.18M |
| Net Income | -59M |
| Diluted EPS | -0.93 |
Balance Sheet
| Total Cash | 45.62M |
| Total Cash/Share | 0.7 |
| Total Debt | 72.69M |
| Total Debt/Equity | 1.07 |
| Current Ratio | 2.9 |
| Book Value Per Share | 1.04 |
Price History
| 52-Week Change | -37.61 |
| 52-Week High | 6.92 |
| 52-Week Low | 1.17 |
| Moving Average 50 Days | 4.43 |
| Moving Average 200 Days | 3.18 |
Statistics
| Average Volume | 291,656 |
| Shares Outstanding | 65.03M |
| % Held by Institutions | 49.41 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
